Skip to main content

Advertisement

SpringerLink
Log in

The impact of hematological malignancies and their treatment on oral health-related quality of life as assessed by the OHIP-14: a systematic review

  • Original Article
  • Published:
Odontology Aims and scope Submit manuscript

Abstract

Patients with hematologic cancers often develop acute and chronic oral complications from their disease and its treatment. These problems could change patients’ oral health-related quality of life (OHRQoL) negatively. Quality of life (QoL) has become an increasingly important outcome measure in oncology. This systematic literature review evaluates the impact of hematological malignancies and their treatment on OHRQoL as assessed by the Oral Health Impact Profile (OHIP-14) questionnaire. Medline through Pubmed and Web of Science were searched through April 2017. Two randomized controlled trials, one cohort study, one cross-sectional study, and one case–control study were included. Heterogeneity across the included studies did not allow for meta-analysis. OHIP-14 domains that were frequently given the highest scores were functional limitation (67%), physical pain (50%), physical disability (50%), and psychological discomfort (33%). The domains that were frequently given the lowest scores were social handicap (100%), social disability (100%), and psychological disability (67%). Insufficient evidence is available to draw any robust conclusions regarding OHRQoL assessed by the OHIP-14 in individuals with hematological malignancies. However, functional limitations because of problems with oral mucosal tissues, the dentition, or dentures, seem to have a larger negative impact on the OHRQoL than social aspects associated with oral health problems. Well-designed larger studies are required to determine effects of hematological malignancies as well as acute and long-term effects of their treatment on patients’ OHRQoL

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Kim HS, Lim CS. Oral signs of acute leukemia for early detection. J Periodontal Implant Sci. 2014;44:293–9.

    Article  Google Scholar 

  2. de Almeida TMX, Cavalcanti EFF, da Silva Freitas A, Pessoa de Magalhães RJ, Maiolino A, Torres SR. Can dentists detect multiple myeloma through oral manifestations? Hematol Transfus Cell Ther. 2018;40:43–9.

    Article  Google Scholar 

  3. Bellm LA, Epstein JB, Rose-Ped A, Martin P, Fuchs HJ. Patient reports of complications of bone marrow transplantation. Support Care Cancer. 2000;8:33–9.

    Article  Google Scholar 

  4. Rogers SN. Quality of life perspectives in patients with oral cancer. Oral Oncol. 2010;46:445–7.

    Article  Google Scholar 

  5. Brand HS, Bots CP, Raber-Durlacher JE. Xerostomia and chronic oral complications among patients treated with haematopoietic stem cell transplantation. Br Dent J. 2009;207(E1):E7.

    Google Scholar 

  6. Elad S, Raber-Durlacher JE, Brennan MT, Saunders DP, Mank AP, Zadik Y, et al. Basic oral care for hematology–oncology patients and hematopoietic stem cell transplantation recipients: a position paper from the joint task force of the Multinational Association of Supportive Care in Cancer/International Society of Oral Oncology (MASCC/ISOO) and the European Society for Blood and Marrow Transplantation (EBMT). Support Care Cancer. 2015;23:223–36.

    Article  Google Scholar 

  7. Treister N, Duncan C, Cutler C, Lehmann L. How we treat oral chronic graft-versus-host disease. Blood. 2012;120:3407–18.

    Article  Google Scholar 

  8. Bottomley A. The cancer patient and quality of life. Oncologist. 2002;7:120–5.

    Article  Google Scholar 

  9. WHOQOL. The World Health Organization Quality of Life assessment (WHOQOL): position paper from the World Health Organization. Soc Sci Med. 1995;41:1403–9.

    Article  Google Scholar 

  10. Slade GD, Spencer AJ. Development and evaluation of the Oral Health Impact Profile. Community Dent Health. 1994;11:3–11.

    PubMed  Google Scholar 

  11. Roumani TI, Oulis CJ, Papagiannopoulou V, Yfantopoulos J. Validation of a Greek version of the oral health impact profile (OHIP-14) in adolescents. Eur Arch Paediatr Dent. 2010;11(suppl 5):247–52.

    Article  Google Scholar 

  12. Higgins JPT, Green S. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011.

  13. Bardellini F, Amadori F, Majorana A. Oral hygiene grade and quality of life in children with chemotherapy-related oral mucositis: a randomized study on the impact of a fluoride toothpaste with salivary enzymes, essential oils, proteins and colostrum extract versus a fluoride toothpaste without menthol. Int J Dent Hyg. 2016;14:314–9.

    Article  Google Scholar 

  14. Silva LC, Sacono NT, Freire MC, Costa LR, Batista AC, Silva GBL. The impact of low-level laser therapy on oral mucositis and quality of life in patients undergoing hematopoietic stem cell transplantation using the oral health impact profile and the functional assessment of cancer therapy-bone marrow transplantation questionnaires. Photomed Laser Surg. 2015;33:357–63.

    Article  Google Scholar 

  15. Bezinelli LM, Eduardo FP, Neves VD, Correa L, Lopes RM, Michel-Crostato E, et al. Quality of life related to oral mucositis of patients undergoing haematopoietic stem cell transplantation and receiving specialised oral care with low-level laser therapy: a prospective observational study. Eur J Cancer Care. 2016;25:6668–74.

    Article  Google Scholar 

  16. Grando LJ, Mello ALSF, Salvato L, Brancher AP, Del Moral JAG, Steffenello-Durigon G. Impact of leukemia and lymphoma chemotherapy on oral cavity and quality of life. Spec Care Dentist. 2015;35:236–42.

    Article  Google Scholar 

  17. Tinoco-Araujo JE, Orti-Raduan ESL, Santos D, Colturato VAR, Souza MP, Mauad MA, et al. Oral health-related quality of life before hematopoietic stem cell transplantation. Clin Oral Investig. 2015;19:2345–9.

    Article  Google Scholar 

  18. Epstein JB, Thariat J, Bensadoun RJ, Barasch A, Murphy BA, Kolnick L, et al. Oral complications of cancer and cancer therapy: from cancer treatment to survivorship. CA Cancer J Clin. 2012;62:400–22.

    Article  Google Scholar 

  19. Naidu MU, Ramana GV, Rani PU, Mohan IK, Suman A, Roy P. Chemotherapy-induced and/or radiation therapy-induced oral mucositis—complicating the treatment of cancer. Neoplasia. 2004;6:423–31.

    Article  Google Scholar 

  20. Weckx LLM, Hidal LBTH, Marcucci G. Oral manifestations of leukemia. Ear Nose Throat J. 1990;49:341–6.

    Google Scholar 

  21. Sonis S, Kunz A. Impact of improved dental services on the frequency of oral complications of cancer therapy for patients with non-head-and-neck malignancies. Oral Surg Oral Med Oral Pathol Oral Radiol. 1988;65:19–22.

    Article  Google Scholar 

  22. Savage DG, Szydlo RM, Goldman JM. Clinical features at diagnosis in 430 patients with chronic myeloid leukaemia seen at a referral centre over a 16-year period. Br J Haematol. 1997;96:111–6.

    Article  Google Scholar 

  23. Woo SB, Lee SJ, Schubert MM. Graft-vs.-host disease. Crit Rev Oral Biol Med. 1997;8:201–16.

    Article  Google Scholar 

  24. Schubert MM, Sullivan KM, Morton TH, Izutsu KT, Peterson DE, Flournoy N, et al. Oral manifestations of chronic graft-v-host disease. Arch Intern Med. 1984;144:1591–5.

    Article  Google Scholar 

  25. Raber-Durlacher JE, Epstein JB, Bresters D, Stern-Zivan L. Oral complications in children with cancer. Eur J Paediatr Dent. 2005;5:3–13.

    Google Scholar 

  26. Shi HB, Masuda M, Umezaki T, Kuratomi Y, Kumamoto Y, Yamamoto T, et al. Irradiation impairment of umami taste in patients with head and neck cancer. Auris Nasus Larynx. 2004;31:401–6.

    Article  Google Scholar 

  27. Watters AL, Epstein JB, Agulnik M. Oral complications of targeted cancer therapies: a narrative literature review. Oral Oncol. 2011;47:441–8.

    Article  Google Scholar 

  28. Comeau TB, Epstein JB, Migas C. Taste and smell dysfunction in patients receiving chemotherapy: a review of current knowledge. Support Care Cancer. 2001;9:575–80.

    Article  Google Scholar 

  29. Raber-Durlacher JE, Brennan MT, Verdonck-de Leeuw IM, Gibson RJ, Eilers JG, Waltimo T, et al. Swallowing dysfunction in cancer patients. Support Care Cancer. 2011;20:433–43.

    Article  Google Scholar 

  30. Van der Meulen MJ, John MT, Naeije M, Lobbezoo F. The Dutch version of the Oral Health Impact Profile (OHIP-NL): translation, reliability and construct validity. BMC Oral Health. 2008;8:11.

    Article  Google Scholar 

  31. Bjordal K, Graeff de A, Fayers PM, Hammerlid E, van Pottelsberghe C, Curran D, et al. A 12 country field study of the EORTC QLQ-C30 (version 3.0) and the head and neck cancer specific module (EORTC QLQ-H&N35) in head and neck patients. EORTC Quality of Life Group. Eur J Cancer. 2000;36:1796–807.

    Article  Google Scholar 

  32. Hjermstad MJ, Bergenmar M, Bjordal K, Fisher SE, Hofmeister D, Montel S, et al. International field testing of the psychometric properties of an EORTC quality of life module for oral health: the EORTC QLQ-OH15. EORTC Quality of Life Group. Support Care Cancer. 2016;2:3915–21.

    Article  Google Scholar 

Download references

Author information

Author notes

  1. Juliette Stolze and Kim C. E. Vlaanderen equally contributed to the manuscript.

Authors and Affiliations

  1. Department of Oral Medicine, Academic Centre for Dentistry (ACTA), Amsterdam, The Netherlands

    Juliette Stolze, Kim C. E. Vlaanderen, Judith E. Raber-Durlacher & Henk S. Brand

  2. Department of Oral Biochemistry, Academic Centre for Dentistry (ACTA), Amsterdam, The Netherlands

    Juliette Stolze & Kim C. E. Vlaanderen

  3. Department of Oral Maxillofacial Surgery, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands

    Judith E. Raber-Durlacher

  4. Department of Oral Biochemistry, Academic Centre for Dentistry (ACTA), room 12N-37, Gustav Mahlerlaan 3004, 1081 LA, Amsterdam, The Netherlands

    Henk S. Brand

Authors
  1. Juliette Stolze
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kim C. E. Vlaanderen
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Judith E. Raber-Durlacher
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Henk S. Brand
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Henk S. Brand.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Stolze, J., Vlaanderen, K.C.E., Raber-Durlacher, J.E. et al. The impact of hematological malignancies and their treatment on oral health-related quality of life as assessed by the OHIP-14: a systematic review. Odontology 108, 511–520 (2020). https://doi.org/10.1007/s10266-019-00479-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10266-019-00479-7

Keywords

Search

Navigation